Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Hara

Showing results (11-20 of 361) with videos related to

Pageof 37
Sort By:
Anticancer Research|August 28, 2004
Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progressionHideaki Miyake, Isao Hara, Hiroshi Eto
BJU International|September 13, 2005
Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancerHideaki Miyake, Isao Hara, Hiroshi Eto
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2009
Male urethral cancer associated with Fournier's gangreneNagahide Matsumura, Yasushi Nakamura, Isao Hara
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[QOL of laparoscopic radical prostatectomy]Yasuo Kohjimoto, Takeshi Inagaki, Isao Hara
Clinical Calcium|October 1, 2011
[Clinical strategies for prevention of drug-induced urinary calculi]Yasuo Kohjimoto, Yumiko Sasaki, Isao Hara
International Journal of Urology : Official Journal of the Japanese Urological Association|October 6, 2005
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinicHideaki Miyake, Isao Hara, Martin E Gleave
International Journal of Oncology|February 11, 2005
Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 modelMototsugu Muramaki, Hideaki Miyake, Isao Hara, et al.
The Journal of Urology|March 17, 2004
Oxidative DNA damage in patients with prostate cancer and its response to treatmentHideaki Miyake, Isao Hara, Sadao Kamidono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapyMototsugu Muramaki, Hideaki Miyake, Isao Hara, et al.
Oncology Reports|December 6, 2005
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progressionMototsugu Muramaki, Hideaki Miyake, Yuji Yamada, et al.
Pageof 37

Showing results (11-20 of 361) with videos related to

Sort By:
Pageof 37
Anticancer Research|August 28, 2004
Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progressionHideaki Miyake, Isao Hara, Hiroshi Eto
BJU International|September 13, 2005
Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancerHideaki Miyake, Isao Hara, Hiroshi Eto
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2009
Male urethral cancer associated with Fournier's gangreneNagahide Matsumura, Yasushi Nakamura, Isao Hara
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[QOL of laparoscopic radical prostatectomy]Yasuo Kohjimoto, Takeshi Inagaki, Isao Hara
Clinical Calcium|October 1, 2011
[Clinical strategies for prevention of drug-induced urinary calculi]Yasuo Kohjimoto, Yumiko Sasaki, Isao Hara
International Journal of Urology : Official Journal of the Japanese Urological Association|October 6, 2005
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinicHideaki Miyake, Isao Hara, Martin E Gleave
International Journal of Oncology|February 11, 2005
Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 modelMototsugu Muramaki, Hideaki Miyake, Isao Hara, et al.
The Journal of Urology|March 17, 2004
Oxidative DNA damage in patients with prostate cancer and its response to treatmentHideaki Miyake, Isao Hara, Sadao Kamidono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapyMototsugu Muramaki, Hideaki Miyake, Isao Hara, et al.
Oncology Reports|December 6, 2005
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progressionMototsugu Muramaki, Hideaki Miyake, Yuji Yamada, et al.
Pageof 37